Princess Máxima Center and International Atomic Energy Agency join forces to improve radiotherapy treatments for children

Date:
1280×1280-internationaal_atoomenergieagentschap-6944110a32a7d

In the presence of Her Majesty Queen Máxima, representatives of the Princess Máxima Center and the International Atomic Energy Agency (IAEA) today signed a four-year partnership aimed at improving practical knowledge on the use of radiotherapy for children with cancer.

Worldwide, each year more than 400,000 children are diagnosed with cancer. For approximately 30% of patients, radiotherapy is an essential part of the overall treatment. This includes, among others, the treatment of brain tumors, leukemia, neuroblastoma, and rhabdomyosarcoma. Radiotherapy can help shrink a tumor prior to surgery or destroy remaining cancer cells after surgery and chemotherapy. In some brain tumors, surgery is not possible, and radiotherapy can be used as a primary treatment.

Collaborating Center

As part of the partnership, the IAEA has designated the Princess Máxima Center as an IAEA Collaborating Center for a period of four years to strengthen pediatric radiation oncology, medical physics and nutrition. Together, the Máxima Center and the IAEA will support international pediatric radiotherapy teams on enhancing their knowledge, skills and expertise through joint activities in education, training, quality improvement and research. 

‘It is our mission to reduce the big disparities in radiotherapy for children around the world; knowledge and training are a key part of that’, says Rafael Mariano Grossi, Director General of the IAEA. ‘I am very pleased that paediatric radiotherapy teams will be able to take what they have learned at the Princess Máxima Center back to colleagues in their home countries, and ultimately to the children and families who count on them.’    

Global disparities

International differences in radiotherapy have multiple causes. First, access to modern equipment is often limited. In addition, there is frequently insufficient training to treat children safely and effectively, with the lowest possible risk of late effects.   

‘We are grateful to the IAEA for giving us the opportunity to provide these radiotherapy oncologists the training that will help them treat children in their own countries more safely and effectively. In addition, it enables us to further advance our knowledge of childhood cancer by working more closely with hospitals in these regions’, says Prof. Dr. Rob Pieters, Chief Máxima International at the Princess Máxima Center. ‘In this way, it substantially contributes to our center’s mission which is shared by pediatric oncologists worldwide: curing every child with cancer, with the best possible quality of life. Everywhere.’

More news

News overview

Utrecht Science Week: Boudewijn Visscher on the Future of Washable Incontinence Materials

In the Netherlands, approximately 85 million kilograms of waste from incontinence materials are generated every year. Washable alternatives could help reduce this waste stream, but switching to washable materials is not yet common practice in healthcare. What is holding back this transition, and what is needed to make washable incontinence materials more widely applicable?

Utrecht Science Week: René van Westen on a colder Netherlands in a warmer world

The Earth is warming, yet the Netherlands could face much colder winters in the future. It may sound contradictory, but the explanation lies in the Atlantic Meridional Overturning Circulation (AMOC), a large system of ocean currents that transports heat and salt through the Atlantic Ocean. This circulation plays an important role in the mild climate that we are accustomed to in the Netherlands.

Opening Utrecht Science Week with keynote by Juliette Legler on the hidden influence of environmental chemicals

On Friday, September 25, the annual science festival ‘Utrecht Science Week’ kicks off once again at Utrecht Science Park. We are pleased to announce that this year, Prof. Dr. Ir. Juliette Legler will deliver the Utrecht Science Lecture. Juliette Legler is Professor of Toxicology at the Faculty of Veterinary Medicine at Utrecht University and leads the ‘One Health Toxicology’ group at the Institute for Risk Assessment Sciences (IRAS).